Within the last two decades, increasing efforts have been made in the field of advanced endoscopic imaging for better disease characterization and early detection of pre-cancerous and cancerous lesions in patients with IBD. Innovations include high-definition endoscopes, both vital (i.e. methylene blue, indigo carmine) and virtual (i.e. narrow band imaging [NBI; Olympus], Fuji intelligent color enhancement [FICE; Fujinon], and i-Scan [Pentax]) chromoendoscopy, and magnification endoscopy [1].